Medicine
Zegalogue 0.6 mg/0.6 mL injection
Zegalogue 0.6 mg/0.6 mL injection is a prescription medicine containing Dasiglucagon for subcutaneous use, marketed by Novo Nordisk, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store ZEGALOGUE in a refrigerator, 2°C to 8°C (36°F to 46°F). Do not freeze…
Key facts
- Active ingredient (INN)
- Dasiglucagon
- Brand
- Zegalogue
- Strength
- 0.6 mg/0.6 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 container of 0.6 mL, 2 package of 0.6 mL and 1 more
- Marketing authorisation holder
- Novo Nordisk
- Manufacturer
- Novo Nordisk
- Origin register
- US FDA, United States
- Storage
- Store ZEGALOGUE in a refrigerator, 2°C to 8°C (36°F to 46°F). Do not freeze. Record the date when the product was removed from the refrigerator in the space provided on the protective case. Do not return the product to the refrigerator after storing at room temperature. ZEGALOGUE can be kept at room temperature between 20°C to 25°C (68°F to 77°F) for up to 12 months.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H04AA02 Dasiglucagon
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 June 2023
- Identifiers
- RxCUI 2535238, 2535243, 2535247 +1DailyMed set ID 14704879-872c-4967-8779-04a3bbdfb4e6NDC 0169-1912, 0169-1913Application NDA214231
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 container in 1 package / 1 syringe, glass in 1 container / .6 mL in 1 syringe, glass | 0169-1912-01 | Novo Nordisk | 26 June 2023 |
| 2 package in 1 carton / 1 container in 1 package / 1 syringe, glass in 1 container / .6 mL in 1 syringe, glass | 0169-1912-02 | Novo Nordisk | 26 June 2023 |
| 1 container in 1 package / 1 syringe, glass in 1 container / .6 mL in 1 syringe, glass | 0169-1913-01 | Novo Nordisk | 26 June 2023 |
| 2 package in 1 carton / 1 container in 1 package / 1 syringe, glass in 1 container / .6 mL in 1 syringe, glass | 0169-1913-02 | Novo Nordisk | 26 June 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Dasiglucagon is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. It is available as injection for subcutaneous use. MedsAcross supplies Dasiglucagon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DasiglucagonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zegalogue prescribing information (Novo Nordisk) · U.S. National Library of Medicine, DailyMed
- Zegalogue: European public assessment report (EPAR) · European Medicines Agency
Need Zegalogue 0.6 mg/0.6 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.